Highlights
- MKS Instruments' valuation using the Discounted Cash Flow (DCF) model estimates its equity value based on future cash flow projections, showing potential overvaluation compared to its current share price.
- The DCF model applies a two-stage growth approach, projecting higher growth initially, followed by a stable growth period, using a conservative terminal growth rate.
- Given the reliance on key assumptions like discount rates and growth projections, it's important to use multiple valuation methods to gain a fuller understanding of the company's value.
MKS Instruments, Inc., a key player in the Technology sector, can be evaluated using various valuation methods, with the Discounted Cash Flow (DCF) model being one such approach. The DCF model projects the company’s future cash flows and discounts them back to their present value to estimate the overall equity value. This method, though one of many, provides useful insights into the potential valuation of the company.
Valuation Estimate Using the Discounted Cash Flow Model
The two-stage DCF model used in this case takes into account two periods of growth: an initial phase of higher growth followed by a more stable, slower growth period. In the first stage, projected cash flows for the next ten years are estimated based on the company’s last reported free cash flow (FCF). In the absence of analyst estimates for MKS Instruments Inc (NASDAQ: MKSI), the model extrapolates FCF, assuming that a company experiencing growth will see its growth rate slow over time, while those with shrinking cash flows will slow their rate of shrinkage.
After projecting the first 10 years of cash flows, the next step is to estimate the Terminal Value, which accounts for all future cash flows beyond the initial growth stage. To calculate this, a conservative growth rate is used, typically based on the 10-year government bond yield—in this case, 2.5%. This ensures that the growth rate remains realistic and does not exceed the broader economy’s growth. Future cash flows, including the Terminal Value, are discounted to present value using a cost of equity of 10%, which is derived from the company's risk profile and the industry’s beta (a measure of volatility).
When these two components—the projected 10-year cash flows and the discounted Terminal Value—are summed, the resulting Total Equity Value for MKS Instruments is approximately US$5.6 billion. This value is then divided by the number of outstanding shares to arrive at a per-share valuation. At the time of writing, MKS Instruments appears to be trading above this valuation, suggesting potential overvaluation relative to the DCF estimate, with a current share price of US$110.
Key Assumptions
The accuracy of the DCF model depends heavily on key inputs, such as the discount rate and projected cash flows. In this case, a discount rate of 10% was used, which is based on the cost of equity. This rate reflects the risk associated with the company’s stock, taking into account market volatility as indicated by a beta of 1.840. It’s worth noting that different assumptions about cash flow growth, discount rates, or industry cyclicality could lead to different valuation outcomes.
It’s also important to recognize that the DCF model does not account for the cyclical nature of the semiconductor industry or potential capital requirements MKS Instruments might face in the future. The model is best used as one component of a broader analysis of the company’s performance and potential.
MKS Instruments, operating within the semiconductor equipment sector, presents an interesting case when evaluated using the Discounted Cash Flow model. Although the model suggests the company may be overvalued relative to its current share price, the outcome depends heavily on the assumptions used in the calculations. The DCF model provides a useful framework for understanding the value of MKS Instruments based on its future cash flow projections, but it is always recommended to complement this analysis with other valuation methods and industry insights for a fuller picture of the company's financial potential.